Korean J Med > Volume 88(6); 2015 > Article
호흡기
The Korean Journal of Medicine 2015;88(6):701-705.
Published online June 1, 2015.
DOI: https://doi.org/10.3904/kjm.2015.88.6.701   
Recurrence of Tuberculosis after Resuming a TNF-Inhibitor in a Patient with Crohn’s Disease
Sojung Park, Ji-Young Yang, Min-joo Song, Jaekyung Cheon, Soo Han Kim, Mi-jin Kim, Kyung-Wook Jo
Department of Internal Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea
크론병 환자에서 종양 괴사 인자 길항제 재시작 후 재발한 결핵
박소정, 양지영, 송민주, 천재경, 김수한, 김미진, 조경욱
울산대학교 의과대학 서울아산병원 내과
Correspondence: 
Kyung-Wook Jo, Tel: +82-2-3010-5783, Fax: +82-2-3010-6968, Email: heathcliff6800@hanmail.net
Received: 22 July 2014   • Revised: 23 September 2014   • Accepted: 8 October 2014
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
Abstract
The use of tumor necrosis factor inhibitors (TNFi) increases a patient’s risk of developing tuberculosis (TB). There is no consensus on whether restarting a TNFi after treating an active TB infection caused by previous TNFi exposure is safe. We report the first case of TB recurrence after recommencing a TNFi in a 37-year-old woman with a history of active TB infection caused by previous TNFi treatment.
Key Words: Tuberculosis; Tumor necrosis factor-alpha; Crohn disease; Recurrence
주제어: 결핵; 종양 괴사 인자; 크론병; 재발


TOOLS
METRICS Graph View
  • 0 Crossref
  •  0 Scopus
  • 3,041 View
  • 38 Download

Editorial Office
101-2501, Lotte Castle President, 109 Mapo-daero, Mapo-gu, Seoul 04146, Korea
Tel: +82-2-2271-6791    Fax: +82-2-790-0993    E-mail: kaim@kams.or.kr                

Copyright © 2024 by The Korean Association of Internal Medicine.

Developed in M2PI

Close layer
prev next